About PURAPHARM Company

The Group is a Hong Kong Chinese medicine company leading the concentrated Chinese medicine formula granule market. It is engaged in R&D, production, marketing and sales of concentrated Chinese medicine formula granule products under its “Nongbenfang” brand. The Group is one of only five overseas enterprises in China that have obtained approval from the Drug Administration to manufacture and sell concentrated Chinese medicine formula granular products in China. Furthermore, the Group is a national standard laboratory certified by CNAS according to ISO 17025, and the Group's test reports have been recognized by more than 70 countries around the world. Since 2004, the Group has been supplying concentrated Chinese medicine formula granular products to most hospitals and traditional Chinese medicine clinics in Hong Kong. Currently, the Group has secured its leading position in the Hong Kong concentrated Chinese medicine formula granular products market. It is the largest supplier, and is also a leading chain of Chinese medicine clinics in Hong Kong. Since its establishment in 1998, the Group has been committed to the modernization and internationalization of traditional Chinese medicine, and has partnered with many internationally renowned scholars and scientific research institutions to establish its position as a technological pioneer in the Chinese medicine market. Through continuous innovation, the Group has been hailed as a leader in the industry in research and development, production, marketing and sales of traditional Chinese medicines, quality control, and basic scientific research. The Group has established its own traditional Chinese medicine research and production base in Nanning, Guangxi, China. The production facilities not only meet national GMP standards, but also meet the Australian Drug Administration TGA standards, which are among the strictest international standards and certifications, and the PIC/S pharmaceutical standards of the International Pharmaceutical Inspection Organization. The Group is also the only manufacturer of concentrated Chinese medicine formula granular products certified and approved by the US Pharmacopeia USP. The Group's own national standard laboratory has obtained CNAS certification according to ISO 17025. This is an international multilateral mutual certification system, making the Group one of the most advanced traditional Chinese medicine research and production facilities in Asia. With advanced development concepts and production technology, a series of traditional Chinese medicine retail products developed by the Group, such as Ganoderma lucidum, Angelica, Yikangsu, and Uffanong, are popular in Hong Kong and overseas markets.